nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—female reproductive system—uterine cancer	0.0244	0.13	CbGeAlD
Pentosan Polysulfate—FGF1—artery—uterine cancer	0.0229	0.122	CbGeAlD
Pentosan Polysulfate—FGF2—myometrium—uterine cancer	0.0149	0.079	CbGeAlD
Pentosan Polysulfate—FGF2—uterine cervix—uterine cancer	0.0116	0.0615	CbGeAlD
Pentosan Polysulfate—FGF2—smooth muscle tissue—uterine cancer	0.0112	0.0597	CbGeAlD
Pentosan Polysulfate—FGF2—decidua—uterine cancer	0.011	0.0586	CbGeAlD
Pentosan Polysulfate—FGF2—endometrium—uterine cancer	0.0105	0.0556	CbGeAlD
Pentosan Polysulfate—FGF2—mammalian vulva—uterine cancer	0.0101	0.0538	CbGeAlD
Pentosan Polysulfate—FGF2—uterus—uterine cancer	0.00965	0.0512	CbGeAlD
Pentosan Polysulfate—FGF1—epithelium—uterine cancer	0.00868	0.0461	CbGeAlD
Pentosan Polysulfate—FGF1—smooth muscle tissue—uterine cancer	0.00836	0.0444	CbGeAlD
Pentosan Polysulfate—FGF1—renal system—uterine cancer	0.00805	0.0428	CbGeAlD
Pentosan Polysulfate—FGF2—female gonad—uterine cancer	0.00789	0.0419	CbGeAlD
Pentosan Polysulfate—FGF2—vagina—uterine cancer	0.00784	0.0417	CbGeAlD
Pentosan Polysulfate—FGF1—female reproductive system—uterine cancer	0.00645	0.0343	CbGeAlD
Pentosan Polysulfate—FGF1—female gonad—uterine cancer	0.00587	0.0312	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—uterine cancer	0.00507	0.0269	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—uterine cancer	0.00377	0.02	CbGeAlD
Pentosan Polysulfate—Anaemia—Progesterone—uterine cancer	0.00139	0.00423	CcSEcCtD
Pentosan Polysulfate—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00421	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Epirubicin—uterine cancer	0.00138	0.00421	CcSEcCtD
Pentosan Polysulfate—Malaise—Progesterone—uterine cancer	0.00136	0.00413	CcSEcCtD
Pentosan Polysulfate—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00409	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Dactinomycin—uterine cancer	0.00133	0.00404	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Progesterone—uterine cancer	0.00128	0.0039	CcSEcCtD
Pentosan Polysulfate—Myalgia—Progesterone—uterine cancer	0.00128	0.0039	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Doxorubicin—uterine cancer	0.00128	0.00389	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Epirubicin—uterine cancer	0.00128	0.00389	CcSEcCtD
Pentosan Polysulfate—Discomfort—Progesterone—uterine cancer	0.00127	0.00385	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00385	CcSEcCtD
Pentosan Polysulfate—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00384	CcSEcCtD
Pentosan Polysulfate—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00382	CcSEcCtD
Pentosan Polysulfate—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00374	CcSEcCtD
Pentosan Polysulfate—Oedema—Progesterone—uterine cancer	0.00123	0.00374	CcSEcCtD
Pentosan Polysulfate—Infection—Progesterone—uterine cancer	0.00122	0.00371	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Dactinomycin—uterine cancer	0.00121	0.00369	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Progesterone—uterine cancer	0.00119	0.00361	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Doxorubicin—uterine cancer	0.00118	0.0036	CcSEcCtD
Pentosan Polysulfate—Anorexia—Progesterone—uterine cancer	0.00117	0.00356	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00353	CcSEcCtD
Pentosan Polysulfate—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00353	CcSEcCtD
Pentosan Polysulfate—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00349	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Epirubicin—uterine cancer	0.00112	0.00342	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00112	0.00341	CcSEcCtD
Pentosan Polysulfate—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00339	CcSEcCtD
Pentosan Polysulfate—Insomnia—Progesterone—uterine cancer	0.00111	0.00338	CcSEcCtD
Pentosan Polysulfate—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00337	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Progesterone—uterine cancer	0.0011	0.00336	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Progesterone—uterine cancer	0.0011	0.00333	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Epirubicin—uterine cancer	0.00109	0.00333	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00332	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Progesterone—uterine cancer	0.00108	0.00329	CcSEcCtD
Pentosan Polysulfate—Alopecia—Dactinomycin—uterine cancer	0.00108	0.00329	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Etoposide—uterine cancer	0.00108	0.00328	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00328	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Epirubicin—uterine cancer	0.00107	0.00326	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Progesterone—uterine cancer	0.00107	0.00325	CcSEcCtD
Pentosan Polysulfate—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00323	CcSEcCtD
Pentosan Polysulfate—Constipation—Progesterone—uterine cancer	0.00105	0.0032	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Doxorubicin—uterine cancer	0.00104	0.00316	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00309	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Progesterone—uterine cancer	0.00101	0.00308	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Doxorubicin—uterine cancer	0.00101	0.00308	CcSEcCtD
Pentosan Polysulfate—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00306	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Progesterone—uterine cancer	0.00101	0.00306	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00304	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000993	0.00302	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Doxorubicin—uterine cancer	0.000992	0.00302	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Epirubicin—uterine cancer	0.000988	0.00301	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Dactinomycin—uterine cancer	0.000988	0.003	CcSEcCtD
Pentosan Polysulfate—Anaemia—Dactinomycin—uterine cancer	0.000984	0.00299	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000981	0.00298	CcSEcCtD
Pentosan Polysulfate—Urticaria—Progesterone—uterine cancer	0.000977	0.00297	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Progesterone—uterine cancer	0.000972	0.00296	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000969	0.00295	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Etoposide—uterine cancer	0.000961	0.00292	CcSEcCtD
Pentosan Polysulfate—Jaundice—Etoposide—uterine cancer	0.000961	0.00292	CcSEcCtD
Pentosan Polysulfate—Malaise—Dactinomycin—uterine cancer	0.00096	0.00292	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Dactinomycin—uterine cancer	0.000953	0.0029	CcSEcCtD
Pentosan Polysulfate—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000953	0.0029	CcSEcCtD
Pentosan Polysulfate—Colitis—Epirubicin—uterine cancer	0.000949	0.00289	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Epirubicin—uterine cancer	0.000933	0.00284	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000918	0.00279	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Doxorubicin—uterine cancer	0.000914	0.00278	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000911	0.00277	CcSEcCtD
Pentosan Polysulfate—Myalgia—Dactinomycin—uterine cancer	0.000907	0.00276	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Progesterone—uterine cancer	0.000906	0.00276	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Epirubicin—uterine cancer	0.000903	0.00275	CcSEcCtD
Pentosan Polysulfate—Discomfort—Dactinomycin—uterine cancer	0.000896	0.00272	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Epirubicin—uterine cancer	0.000894	0.00272	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Epirubicin—uterine cancer	0.000894	0.00272	CcSEcCtD
Pentosan Polysulfate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000885	0.00269	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000881	0.00268	CcSEcCtD
Pentosan Polysulfate—Colitis—Doxorubicin—uterine cancer	0.000878	0.00267	CcSEcCtD
Pentosan Polysulfate—Pruritus—Progesterone—uterine cancer	0.00087	0.00265	CcSEcCtD
Pentosan Polysulfate—Oedema—Dactinomycin—uterine cancer	0.000869	0.00264	CcSEcCtD
Pentosan Polysulfate—Infection—Dactinomycin—uterine cancer	0.000863	0.00263	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Doxorubicin—uterine cancer	0.000863	0.00263	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Dactinomycin—uterine cancer	0.000851	0.00259	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Progesterone—uterine cancer	0.000841	0.00256	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Doxorubicin—uterine cancer	0.000836	0.00254	CcSEcCtD
Pentosan Polysulfate—Anorexia—Dactinomycin—uterine cancer	0.000828	0.00252	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Doxorubicin—uterine cancer	0.000827	0.00251	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Doxorubicin—uterine cancer	0.000827	0.00251	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000821	0.0025	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Epirubicin—uterine cancer	0.000817	0.00248	CcSEcCtD
Pentosan Polysulfate—Dizziness—Progesterone—uterine cancer	0.000813	0.00247	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000792	0.00241	CcSEcCtD
Pentosan Polysulfate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000788	0.0024	CcSEcCtD
Pentosan Polysulfate—Alopecia—Etoposide—uterine cancer	0.000782	0.00238	CcSEcCtD
Pentosan Polysulfate—Vomiting—Progesterone—uterine cancer	0.000782	0.00238	CcSEcCtD
Pentosan Polysulfate—Rash—Progesterone—uterine cancer	0.000775	0.00236	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Progesterone—uterine cancer	0.000775	0.00236	CcSEcCtD
Pentosan Polysulfate—Headache—Progesterone—uterine cancer	0.00077	0.00234	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000762	0.00232	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—uterine cancer	0.000756	0.0023	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dactinomycin—uterine cancer	0.000756	0.0023	CcSEcCtD
Pentosan Polysulfate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000737	0.00224	CcSEcCtD
Pentosan Polysulfate—Nausea—Progesterone—uterine cancer	0.00073	0.00222	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dactinomycin—uterine cancer	0.000716	0.00218	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Etoposide—uterine cancer	0.000715	0.00217	CcSEcCtD
Pentosan Polysulfate—Anaemia—Etoposide—uterine cancer	0.000712	0.00217	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000711	0.00216	CcSEcCtD
Pentosan Polysulfate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000708	0.00215	CcSEcCtD
Pentosan Polysulfate—Affect lability—Epirubicin—uterine cancer	0.000706	0.00215	CcSEcCtD
Pentosan Polysulfate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000703	0.00214	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000702	0.00213	CcSEcCtD
Pentosan Polysulfate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000698	0.00212	CcSEcCtD
Pentosan Polysulfate—Malaise—Etoposide—uterine cancer	0.000695	0.00211	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Etoposide—uterine cancer	0.00069	0.0021	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dactinomycin—uterine cancer	0.000687	0.00209	CcSEcCtD
Pentosan Polysulfate—Mood swings—Epirubicin—uterine cancer	0.00068	0.00207	CcSEcCtD
Pentosan Polysulfate—Dehydration—Epirubicin—uterine cancer	0.000667	0.00203	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Epirubicin—uterine cancer	0.000662	0.00201	CcSEcCtD
Pentosan Polysulfate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000662	0.00201	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—uterine cancer	0.000653	0.00199	CcSEcCtD
Pentosan Polysulfate—Discomfort—Etoposide—uterine cancer	0.000648	0.00197	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Dactinomycin—uterine cancer	0.00064	0.00195	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—uterine cancer	0.000635	0.00193	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—uterine cancer	0.000629	0.00191	CcSEcCtD
Pentosan Polysulfate—Infection—Etoposide—uterine cancer	0.000625	0.0019	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—uterine cancer	0.000617	0.00188	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Etoposide—uterine cancer	0.000616	0.00187	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—uterine cancer	0.000613	0.00186	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Etoposide—uterine cancer	0.000608	0.00185	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—uterine cancer	0.000604	0.00184	CcSEcCtD
Pentosan Polysulfate—Anorexia—Etoposide—uterine cancer	0.0006	0.00182	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dactinomycin—uterine cancer	0.000595	0.00181	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—uterine cancer	0.000587	0.00179	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—uterine cancer	0.000573	0.00174	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—uterine cancer	0.000566	0.00172	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Etoposide—uterine cancer	0.000565	0.00172	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—uterine cancer	0.000564	0.00172	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—uterine cancer	0.000561	0.00171	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Etoposide—uterine cancer	0.000561	0.00171	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—uterine cancer	0.000559	0.0017	CcSEcCtD
Pentosan Polysulfate—Vomiting—Dactinomycin—uterine cancer	0.000553	0.00168	CcSEcCtD
Pentosan Polysulfate—Rash—Dactinomycin—uterine cancer	0.000548	0.00167	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Etoposide—uterine cancer	0.000547	0.00166	CcSEcCtD
Pentosan Polysulfate—Jaundice—Epirubicin—uterine cancer	0.000539	0.00164	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—uterine cancer	0.000539	0.00164	CcSEcCtD
Pentosan Polysulfate—Constipation—Etoposide—uterine cancer	0.000538	0.00164	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—uterine cancer	0.000537	0.00163	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—uterine cancer	0.00053	0.00161	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—uterine cancer	0.00053	0.00161	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—uterine cancer	0.000527	0.0016	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000524	0.00159	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—uterine cancer	0.000522	0.00159	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—uterine cancer	0.000521	0.00159	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—uterine cancer	0.000519	0.00158	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—uterine cancer	0.000519	0.00158	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Etoposide—uterine cancer	0.000518	0.00158	CcSEcCtD
Pentosan Polysulfate—Nausea—Dactinomycin—uterine cancer	0.000516	0.00157	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Etoposide—uterine cancer	0.000514	0.00156	CcSEcCtD
Pentosan Polysulfate—Urticaria—Etoposide—uterine cancer	0.0005	0.00152	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—uterine cancer	0.000499	0.00152	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—uterine cancer	0.000499	0.00152	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—uterine cancer	0.000498	0.00151	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Etoposide—uterine cancer	0.000497	0.00151	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—uterine cancer	0.000497	0.00151	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—uterine cancer	0.000493	0.0015	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—uterine cancer	0.00049	0.00149	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—uterine cancer	0.000488	0.00148	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—uterine cancer	0.000482	0.00147	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—uterine cancer	0.00048	0.00146	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Etoposide—uterine cancer	0.000463	0.00141	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—uterine cancer	0.000463	0.00141	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—uterine cancer	0.00046	0.0014	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—uterine cancer	0.000456	0.00139	CcSEcCtD
Pentosan Polysulfate—Pruritus—Etoposide—uterine cancer	0.000445	0.00135	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—uterine cancer	0.000439	0.00133	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Etoposide—uterine cancer	0.00043	0.00131	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—uterine cancer	0.000428	0.0013	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—uterine cancer	0.000426	0.00129	CcSEcCtD
Pentosan Polysulfate—Dizziness—Etoposide—uterine cancer	0.000416	0.00126	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—uterine cancer	0.000406	0.00123	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—uterine cancer	0.000401	0.00122	CcSEcCtD
Pentosan Polysulfate—Vomiting—Etoposide—uterine cancer	0.0004	0.00122	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—uterine cancer	0.000399	0.00121	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—uterine cancer	0.000397	0.00121	CcSEcCtD
Pentosan Polysulfate—Rash—Etoposide—uterine cancer	0.000397	0.00121	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Etoposide—uterine cancer	0.000396	0.00121	CcSEcCtD
Pentosan Polysulfate—Headache—Etoposide—uterine cancer	0.000394	0.0012	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—uterine cancer	0.000394	0.0012	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—uterine cancer	0.00039	0.00118	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—uterine cancer	0.000387	0.00118	CcSEcCtD
Pentosan Polysulfate—Nausea—Etoposide—uterine cancer	0.000374	0.00114	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—uterine cancer	0.000371	0.00113	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—uterine cancer	0.000369	0.00112	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—uterine cancer	0.000368	0.00112	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—uterine cancer	0.000368	0.00112	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—uterine cancer	0.000367	0.00112	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—uterine cancer	0.000363	0.00111	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—uterine cancer	0.00036	0.0011	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—uterine cancer	0.000358	0.00109	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—uterine cancer	0.000353	0.00107	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—uterine cancer	0.00035	0.00107	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—uterine cancer	0.000345	0.00105	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—uterine cancer	0.000341	0.00104	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—uterine cancer	0.00034	0.00103	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—uterine cancer	0.00034	0.00103	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—uterine cancer	0.000336	0.00102	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—uterine cancer	0.000336	0.00102	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—uterine cancer	0.000326	0.000992	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—uterine cancer	0.000324	0.000986	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000321	0.000977	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—uterine cancer	0.000319	0.000971	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—uterine cancer	0.000319	0.00097	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Epirubicin—uterine cancer	0.000317	0.000963	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000315	0.000959	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—uterine cancer	0.000314	0.000956	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—uterine cancer	0.000311	0.000946	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—uterine cancer	0.00031	0.000944	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—uterine cancer	0.000307	0.000932	CcSEcCtD
Pentosan Polysulfate—Constipation—Epirubicin—uterine cancer	0.000302	0.000917	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000297	0.000904	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—uterine cancer	0.000295	0.000897	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—uterine cancer	0.000293	0.000891	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—uterine cancer	0.000291	0.000885	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—uterine cancer	0.000291	0.000884	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000288	0.000877	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—uterine cancer	0.000287	0.000873	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—uterine cancer	0.000284	0.000862	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—uterine cancer	0.00028	0.000852	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—uterine cancer	0.000279	0.000848	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—uterine cancer	0.000279	0.000848	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—uterine cancer	0.000269	0.000818	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000267	0.000811	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—uterine cancer	0.00026	0.00079	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—uterine cancer	0.000259	0.000788	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—uterine cancer	0.000258	0.000784	CcSEcCtD
Pentosan Polysulfate—Pruritus—Epirubicin—uterine cancer	0.000249	0.000759	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Epirubicin—uterine cancer	0.000241	0.000734	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—uterine cancer	0.00024	0.000731	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—uterine cancer	0.000233	0.000709	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—uterine cancer	0.000231	0.000702	CcSEcCtD
Pentosan Polysulfate—Vomiting—Epirubicin—uterine cancer	0.000224	0.000682	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—uterine cancer	0.000223	0.000679	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—uterine cancer	0.000222	0.000676	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—uterine cancer	0.000222	0.000675	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—uterine cancer	0.000221	0.000672	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—uterine cancer	0.000216	0.000656	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—uterine cancer	0.000209	0.000637	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—uterine cancer	0.000207	0.000631	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—uterine cancer	0.000206	0.000626	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—uterine cancer	0.000206	0.000625	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—uterine cancer	0.000204	0.000622	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—uterine cancer	0.000194	0.000589	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—PTEN—uterine cancer	0.000155	0.00032	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000154	0.000319	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKR1C3—uterine cancer	0.000154	0.000319	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—HRAS—uterine cancer	0.000154	0.000318	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EP300—uterine cancer	0.000154	0.000318	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKR1C1—uterine cancer	0.000154	0.000318	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—HRAS—uterine cancer	0.000153	0.000317	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	0.000152	0.000315	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—AKT1—uterine cancer	0.000152	0.000314	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—AKT1—uterine cancer	0.000152	0.000314	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—AKT1—uterine cancer	0.000152	0.000314	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FBXW7—uterine cancer	0.00015	0.000311	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—AKT1—uterine cancer	0.00015	0.000311	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HMGA1—uterine cancer	0.00015	0.000311	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—PIK3CA—uterine cancer	0.00015	0.00031	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—AKT1—uterine cancer	0.000149	0.000309	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—AKT1—uterine cancer	0.000149	0.000308	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FBXW7—uterine cancer	0.000149	0.000308	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—AKT1—uterine cancer	0.000148	0.000307	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—AKT1—uterine cancer	0.000148	0.000307	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—AKT1—uterine cancer	0.000148	0.000306	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—AKT1—uterine cancer	0.000147	0.000304	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—NRAS—uterine cancer	0.000146	0.000302	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STK11—uterine cancer	0.000145	0.0003	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—HRAS—uterine cancer	0.000145	0.0003	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—uterine cancer	0.000145	0.0003	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—NRAS—uterine cancer	0.000144	0.000297	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000143	0.000295	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—AKT1—uterine cancer	0.00014	0.000291	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKR1C1—uterine cancer	0.00014	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	0.000139	0.000287	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—uterine cancer	0.000138	0.000286	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—AKT1—uterine cancer	0.000138	0.000286	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—AKT1—uterine cancer	0.000138	0.000286	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—NRAS—uterine cancer	0.000138	0.000286	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—KRAS—uterine cancer	0.000138	0.000285	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FBXW7—uterine cancer	0.000137	0.000284	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—AKT1—uterine cancer	0.000137	0.000284	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CDH1—uterine cancer	0.000136	0.000282	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SOCS3—uterine cancer	0.000136	0.000281	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—AKT1—uterine cancer	0.000136	0.000281	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—AKT1—uterine cancer	0.000135	0.00028	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	0.000134	0.000278	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SOCS3—uterine cancer	0.000133	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDH1—uterine cancer	0.00013	0.00027	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.00013	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN2B—uterine cancer	0.00013	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—AKT1—uterine cancer	0.000128	0.000265	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—PIK3CA—uterine cancer	0.000126	0.000262	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF1R—uterine cancer	0.000126	0.000261	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—KRAS—uterine cancer	0.000125	0.00026	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDH1—uterine cancer	0.000124	0.000258	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—ERBB2—uterine cancer	0.000124	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—KRAS—uterine cancer	0.000124	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	0.000122	0.000254	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SOCS3—uterine cancer	0.000122	0.000252	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—ERBB2—uterine cancer	0.00012	0.000248	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KRAS—uterine cancer	0.000119	0.000246	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SMAD3—uterine cancer	0.000119	0.000246	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKR1C3—uterine cancer	0.000118	0.000245	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN2B—uterine cancer	0.000118	0.000244	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—HRAS—uterine cancer	0.000117	0.000242	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—PIK3CA—uterine cancer	0.000115	0.000239	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PGR—uterine cancer	0.000115	0.000238	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ERBB2—uterine cancer	0.000115	0.000238	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—PIK3CA—uterine cancer	0.000114	0.000235	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FGFR2—uterine cancer	0.000113	0.000234	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FGFR2—uterine cancer	0.000111	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CDKN1B—uterine cancer	0.000111	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ERBB2—uterine cancer	0.00011	0.000228	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—YWHAE—uterine cancer	0.00011	0.000227	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—ERBB2—uterine cancer	0.000109	0.000226	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—PIK3CA—uterine cancer	0.000109	0.000226	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CTNNB1—uterine cancer	0.000108	0.000224	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKR1C3—uterine cancer	0.000108	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SMAD3—uterine cancer	0.000108	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN2B—uterine cancer	0.000107	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—HRAS—uterine cancer	0.000107	0.000221	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CDKN1B—uterine cancer	0.000107	0.000221	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FBXW7—uterine cancer	0.000105	0.000218	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—HRAS—uterine cancer	0.000105	0.000218	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PGR—uterine cancer	0.000105	0.000217	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ERBB2—uterine cancer	0.000105	0.000217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CTNNB1—uterine cancer	0.000105	0.000217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—AKT1—uterine cancer	0.000103	0.000214	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGFR2—uterine cancer	0.000103	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PTEN—uterine cancer	0.000102	0.000212	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDKN1B—uterine cancer	0.000102	0.000211	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—ERBB2—uterine cancer	0.000102	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FGFR2—uterine cancer	0.000101	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CDKN1B—uterine cancer	0.000101	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HRAS—uterine cancer	0.000101	0.000209	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EP300—uterine cancer	0.000101	0.000208	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—YWHAE—uterine cancer	0.0001	0.000207	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTHFR—uterine cancer	9.88e-05	0.000205	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PTEN—uterine cancer	9.81e-05	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SMAD3—uterine cancer	9.81e-05	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EP300—uterine cancer	9.75e-05	0.000202	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDKN1B—uterine cancer	9.72e-05	0.000201	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ESR1—uterine cancer	9.69e-05	0.000201	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CTNNB1—uterine cancer	9.62e-05	0.000199	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FBXW7—uterine cancer	9.6e-05	0.000199	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CTNNB1—uterine cancer	9.56e-05	0.000198	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—uterine cancer	9.53e-05	0.000197	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—uterine cancer	9.42e-05	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NRAS—uterine cancer	9.42e-05	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CDKN1B—uterine cancer	9.4e-05	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PTEN—uterine cancer	9.38e-05	0.000194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FGFR2—uterine cancer	9.36e-05	0.000194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PTEN—uterine cancer	9.32e-05	0.000193	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—uterine cancer	9.28e-05	0.000192	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STK11—uterine cancer	9.21e-05	0.000191	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NRAS—uterine cancer	9.12e-05	0.000189	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTHFR—uterine cancer	9.01e-05	0.000187	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PTEN—uterine cancer	8.95e-05	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EP300—uterine cancer	8.94e-05	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—uterine cancer	8.91e-05	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EP300—uterine cancer	8.89e-05	0.000184	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CTNNB1—uterine cancer	8.88e-05	0.000184	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NRAS—uterine cancer	8.76e-05	0.000181	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTEN—uterine cancer	8.66e-05	0.000179	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SOCS3—uterine cancer	8.62e-05	0.000179	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL2—uterine cancer	8.53e-05	0.000177	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STK11—uterine cancer	8.4e-05	0.000174	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NRAS—uterine cancer	8.37e-05	0.000173	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NRAS—uterine cancer	8.31e-05	0.000172	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDH1—uterine cancer	8.27e-05	0.000171	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EP300—uterine cancer	8.26e-05	0.000171	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN2B—uterine cancer	8.25e-05	0.000171	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—uterine cancer	8.1e-05	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1R—uterine cancer	8.01e-05	0.000166	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NRAS—uterine cancer	7.98e-05	0.000165	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SOCS3—uterine cancer	7.86e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—uterine cancer	7.85e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NRAS—uterine cancer	7.72e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDH1—uterine cancer	7.54e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—uterine cancer	7.54e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SMAD3—uterine cancer	7.54e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN2B—uterine cancer	7.53e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1R—uterine cancer	7.31e-05	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—uterine cancer	7.21e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—uterine cancer	7.2e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGFR2—uterine cancer	7.19e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—uterine cancer	7.16e-05	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—uterine cancer	7.11e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—uterine cancer	6.98e-05	0.000145	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—uterine cancer	6.92e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—uterine cancer	6.89e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—uterine cancer	6.87e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SMAD3—uterine cancer	6.87e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—uterine cancer	6.74e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—uterine cancer	6.67e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—uterine cancer	6.65e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—uterine cancer	6.62e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1B—uterine cancer	6.59e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—uterine cancer	6.57e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR2—uterine cancer	6.55e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1B—uterine cancer	6.46e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—uterine cancer	6.44e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—uterine cancer	6.41e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—uterine cancer	6.37e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—uterine cancer	6.31e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CTNNB1—uterine cancer	6.22e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ESR1—uterine cancer	6.15e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—uterine cancer	6.12e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—uterine cancer	6.11e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CTNNB1—uterine cancer	6.11e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—uterine cancer	6.08e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—uterine cancer	6.08e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—uterine cancer	6.06e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1B—uterine cancer	5.97e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—uterine cancer	5.95e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1B—uterine cancer	5.9e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—uterine cancer	5.89e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—uterine cancer	5.88e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—uterine cancer	5.84e-05	0.000121	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EP300—uterine cancer	5.78e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EP300—uterine cancer	5.68e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—uterine cancer	5.66e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—uterine cancer	5.65e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CTNNB1—uterine cancer	5.64e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ESR1—uterine cancer	5.61e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CTNNB1—uterine cancer	5.57e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—uterine cancer	5.5e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—uterine cancer	5.48e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1B—uterine cancer	5.44e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—uterine cancer	5.43e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL2—uterine cancer	5.41e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—uterine cancer	5.41e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—uterine cancer	5.4e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—uterine cancer	5.37e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—uterine cancer	5.31e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EP300—uterine cancer	5.24e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EP300—uterine cancer	5.18e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—uterine cancer	5.16e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CTNNB1—uterine cancer	5.14e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—uterine cancer	5.01e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—uterine cancer	4.99e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL2—uterine cancer	4.94e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—uterine cancer	4.9e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—uterine cancer	4.84e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EP300—uterine cancer	4.78e-05	9.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—uterine cancer	4.66e-05	9.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—uterine cancer	4.57e-05	9.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—uterine cancer	4.51e-05	9.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—uterine cancer	4.47e-05	9.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—uterine cancer	4.28e-05	8.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—uterine cancer	4.28e-05	8.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—uterine cancer	4.22e-05	8.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—uterine cancer	4.2e-05	8.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1B—uterine cancer	4.18e-05	8.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—uterine cancer	4.17e-05	8.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—uterine cancer	4.14e-05	8.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—uterine cancer	4.12e-05	8.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—uterine cancer	3.96e-05	8.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNB1—uterine cancer	3.95e-05	8.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—uterine cancer	3.9e-05	8.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—uterine cancer	3.89e-05	8.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—uterine cancer	3.88e-05	8.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—uterine cancer	3.85e-05	7.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—uterine cancer	3.85e-05	7.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—uterine cancer	3.83e-05	7.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1B—uterine cancer	3.81e-05	7.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EP300—uterine cancer	3.67e-05	7.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNB1—uterine cancer	3.6e-05	7.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—uterine cancer	3.59e-05	7.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—uterine cancer	3.54e-05	7.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—uterine cancer	3.54e-05	7.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—uterine cancer	3.51e-05	7.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—uterine cancer	3.49e-05	7.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—uterine cancer	3.48e-05	7.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—uterine cancer	3.43e-05	7.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—uterine cancer	3.43e-05	7.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EP300—uterine cancer	3.35e-05	6.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—uterine cancer	3.27e-05	6.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—uterine cancer	3.17e-05	6.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—uterine cancer	3.17e-05	6.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—uterine cancer	3.13e-05	6.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—uterine cancer	3.13e-05	6.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—uterine cancer	2.96e-05	6.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—uterine cancer	2.89e-05	5.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—uterine cancer	2.72e-05	5.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—uterine cancer	2.69e-05	5.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—uterine cancer	2.63e-05	5.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—uterine cancer	2.51e-05	5.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—uterine cancer	2.48e-05	5.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—uterine cancer	2.4e-05	4.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—uterine cancer	2.29e-05	4.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—uterine cancer	2.22e-05	4.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—uterine cancer	2.02e-05	4.19e-05	CbGpPWpGaD
